BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache
NCT: NCT07136740 · RECRUITING
Brief Summary
The purpose of this study is to test a therapist-independent home-based smartphone app-based biofeedback treatment in adults with tension type headache. The aim of the study is to assess the safety and performance of the Cerebri-TTH biofeedback device as a preventive treatment in adults with frequent and chronic tension type headache. The primary endpoint of the study is the change in the mean Area-Under-the-headache-Curve (AUC) from baseline to the last 28-day period during the treatment phase, in the treatment group as compared to the placebo group.
Frequently Asked Questions
What is BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache?
BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache is a clinical trial registered under NCT07136740. Current status: RECRUITING.
What is the status of NCT07136740?
The current status of NCT07136740 (BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache) is: RECRUITING.
When did BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache start?
BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache started on 2025-10-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.